Guillermo Reglero Rada-rekin lankidetzan egindako argitalpenak (10)

2015

  1. Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancer

    European Journal of Cancer, Vol. 51, Núm. 1, pp. 1-8

  2. ColoLipidGene: Signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients

    Oncotarget, Vol. 6, Núm. 9, pp. 7348-7363

  3. Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy

    Nutrition and Cancer, Vol. 67, Núm. 8, pp. 1223-1231

  4. The Ellagic Acid Derivative 4,4′-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16

    Journal of Pharmacology and Experimental Therapeutics, Vol. 353, Núm. 2, pp. 433-444

2014

  1. Expression of MicroRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of rosemary diterpenes in colon and pancreatic cancer

    PLoS ONE, Vol. 9, Núm. 6

  2. Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer

    Molecular Oncology, Vol. 8, Núm. 8, pp. 1469-1481

  3. Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells

    Electrophoresis, Vol. 35, Núm. 11, pp. 1719-1727

2013

  1. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells

    Pharmacological Research, Vol. 72, pp. 61-68

  2. Supercritical rosemary extracts, their antioxidant activity and effect on hepatic tumor progression

    Journal of Supercritical Fluids, Vol. 79, pp. 101-108

2010

  1. Nutritional Genomics for the Determination of the Mechanism of Action of the Beneficial Effect of Bioactive Extracts in Tumor Progression

    JOURNAL OF NUTRIGENETICS AND NUTRIGENOMICS